Q-linea AB secures SEK 151.5 million in funding

UPPSALA, Sweden, June 18, 2018 – Q-linea AB, a diagnostic company focused on developing and delivering solutions to accurately and rapidly diagnose infectious diseases, announced today that the company secured SEK 151.5 million from existing shareholders and a group of Swedish investors. Lead investors were Investment AB Öresund and the Fourth AP fund.

Q-linea has secured SEK 151.5 million, before transaction costs, in a private placement. The shares were subscribed for by existing shareholders and new investors, including Öresund AB and the Fourth AP Fund. In the transaction SEK 10 million was converted based on the shares quota value to Nexttobei.

“Q-linea is in an intensive development phase aiming for FDA-approval and CE-marking of our key product ASTar™. The funding will allow us to further intensify these efforts. We are very pleased that the investment opportunity in Q-linea attracted such a great interest, and we are proud to have strengthened our already strong ownership base with such noteworthy investors”, said Jonas Jarvius, CEO and co-founder of Q-linea.

Carnegie Investment Bank acted as financial advisor for the company in conjunction with the transaction.

For more information, please contact:

Jonas Jarvius, Jonas.Jarvius@qlinea.com, 070-323 77 60
Anders Lundin, Anders.Lundin@qlinea.com, 070-252 55 58

About Q-linea

Q-linea AB is a diagnostic company focused on developing and delivering solutions for healthcare providers, enabling them to accurately diagnose and treat infectious diseases in the shortest possible time. Our premium product ASTar™, a fully automated instrument for antibiotic susceptibility testing (AST) will drastically reduce the time to correct antibiotic treatment. The company was founded in Uppsala, Sweden, in 2008 by scientists from the Rudbeck Laboratory at Uppsala University, together with Olink AB and the Uppsala University holding company, UUAB. www.qlinea.com

About Investment AB Öresund

Investment AB Öresund is a listed investment company active in asset management. Öresund’s overall goal as an investment company is to run its business in such a way as to generate a healthy long-term return for its shareholders. The investment portfolio includes approximately 25 companies. Öresund has a net asset value of SEK 5.6 billion and a net cash position of SEK 305 million (as of Q1 2018). Öresund’s main owner is the Qviberg-family.

About Fourth AP Fund

The Fourth Swedish National Pension Fund is one of five buffer funds in the Swedish public pension system. The Fourth Swedish National Pension Fund’s mission is to contribute to economic safety for today’s and tomorrow’s pensioners through managing part of the national Swedish pension system’s buffer capital. The Fourth Swedish National Pension Fund’s long term perspective, responsibility as an owner, and large engagement for sustainability creates possibilities for high returns at a low cost. In this way, the Fourth Swedish National Pension Fund acts for more secure pensions. At year end 2017, the Fourth Swedish National Pension Fund’s portfolio value amounted to SEK 357 billion, whereof SEK 200 billion worth of shares.

i The reason for the share quota issue to Nexttobe AB was that, on December 31 2017, Nexttobe AB gave an unconditional shareholder contribution of SEK 10 million to the company and that Nexttobe AB, through the issue, overall agreed to pay the same rate as the external investors and thus was not disadvantaged in relation to other owners in Q-linea.